Fluphenazine decanoate 25 mg
Products billed under this code include Fluphenazine Decanoate.
Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Fluphenazine Decanoate.
Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Fluphenazine Decanoate | Hikma Pharmaceuticals USA Inc. | 00143-9529-01 | 5 | $30.87 |
| Fluphenazine Decanoate | Sagent Pharmaceuticals | 25021-0838-05 | 5 | $30.87 |
| Fluphenazine Decanoate | Endo USA, Inc. | 42023-0129-01 | 5 | $30.87 |
| Fluphenazine Decanoate | Endo USA, Inc. | 42023-0129-89 | 5 | $30.87 |
| Fluphenazine Decanoate | Eugia US LLC | 55150-0267-05 | 5 | $30.87 |
| Fluphenazine Decanoate | FreseniUS Kabi USA, LLC | 63323-0272-05 | 5 | $30.87 |
| Fluphenazine Decanoate | Mylan Institutional LLC | 67457-0359-59 | 5 | $30.87 |
| Fluphenazine Decanoate | Novadoz Pharmaceuticals LLC | 72205-0100-01 | 5 | $30.87 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $6.174 | +$0.393 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted September 17, 2026 |
| 3Q26 | $5.781 | +$0.195 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted September 15, 2026 |
| 2Q26 | $5.586 | −$0.612 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted September 15, 2026 |
| 1Q26 | $6.198 | −$1.107 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted September 15, 2026 |
| 4Q25 | $7.305 | −$0.227 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted September 8, 2026 |
| 3Q25 | $7.532 | −$1.296 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted March 10, 2026 |
| 2Q25 | $8.828 | −$0.582 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted March 10, 2026 |
| 1Q25 | $9.41 | −$0.799 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted December 19, 2025 |
| 4Q24 | $10.209 | +$1.285 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 11, 2025 |
| 3Q24 | $8.924 | −$0.796 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 11, 2025 |
| 2Q24 | $9.72 | +$0.57 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted March 11, 2025 |
| 1Q24 | $9.15 | −$0.723 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted December 19, 2024 |
| 4Q23 | $9.873 | −$1.079 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted October 10, 2024 |
| 3Q23 | $10.952 | +$1.353 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 5, 2024 |
| 2Q23 | $9.599 | +$0.004 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted February 23, 2024 |
| 1Q23 | $9.595 | −$0.918 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted December 6, 2023 |
| 4Q22 | $10.513 | +$0.669 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 22, 2023 |
| 3Q22 | $9.844 | −$1.042 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 9, 2023 |
| 2Q22 | $10.886 | +$0.605 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted December 14, 2022 |
| 1Q22 | $10.281 | −$0.018 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 8, 2022 |
| 4Q21 | $10.299 | −$1.286 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 2, 2022 |
| 3Q21 | $11.585 | −$1.295 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted June 2, 2022 |
| 2Q21 | $12.88 | +$1.26 | 25 MG | Fluphenazine decanoate 25 mg | v1, posted March 1, 2022 |
| 1Q21 | $11.62 | – | 25 MG | Fluphenazine decanoate 25 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.